about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaHypoxia-inducible factors as molecular targets for liver diseasesClinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysisGenetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaRecent advances in the molecular diagnostics of gastric cancerImmunology of hepatocellular carcinomaKlotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinomaEmerging role of Toll-like receptor 4 in hepatocellular carcinomaHBV induced HCC: major risk factors from genetic to molecular levelDiagnostic and therapeutic management of hepatocellular carcinomaRole of innate immunity in the development of hepatocellular carcinomaLong noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinomaMicrobiome, inflammation, and cancerGenome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinomaInsights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionClinical significance of increased expression of Nijmegen breakage syndrome gene (NBS1) in human primary liver cancerKlotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinomaAn efficient targeted drug delivery through apotransferrin loaded nanoparticlesThe role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinomaGenome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, ChinaGenetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study.MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinomaHedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway.A novel biomarker TERTmRNA is applicable for early detection of hepatoma.Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.Involvement of DNA damage response pathways in hepatocellular carcinoma.Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype.Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.Molecular genetics of hepatocellular neoplasia.N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathwaysMicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.Cytohesin-3 is upregulated in hepatocellular carcinoma and contributes to tumor growth and vascular invasion.Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignanciesImmunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells.HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer.Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.
P2860
Q26743361-E62734A0-F897-4237-8480-C69B9BF8B269Q26752304-159B2915-D7DE-49CC-AA3F-C885464BFF2CQ26784351-E0D9F717-2077-452A-A338-CA39793AFD83Q26784412-EFA4AF48-AA6F-4DA5-967F-353A723534BEQ26785548-CD43B5CD-D060-4634-8D0A-0BD4CCFBB624Q26795411-51B7EF07-F3BA-41AA-8037-283B3490E806Q26799745-F4BDE763-806B-4994-9690-B06C397E2CA7Q26824613-0EB2A832-E1E0-44AB-9F95-A462F33F36ACQ26825274-DFC956DA-7663-4850-98CD-ECF952A26547Q26999043-BF512289-A7E9-4042-8DD2-7F88BE82A394Q27024780-A312692B-FBA5-4A3E-BDC6-9DD95B28480BQ27026667-55458CBD-04F3-41A0-998D-FD27CAB4AF44Q27027582-C7AB0DCE-A6CD-4BCD-A207-8CB0EACE29CFQ27324064-8B0A79CB-2DE5-4C94-BFAC-CA23BCD00E1AQ28080281-BDD39868-1945-419B-AC3C-5294D0EC0F2DQ28265438-F8C4697B-83D4-4D17-A44D-44EA9FEDEE87Q28287609-52F7E58D-2BB9-493B-8C59-A52062C940E9Q28476276-CBB7F401-2E6B-4CD9-A254-67687DCE4A27Q28477884-05966A44-67FA-4BE4-9493-A7107AF8C6C5Q28538135-886A91FB-B8DD-4EA2-AA1C-5AB4B5235DD2Q31102071-67C2899C-409F-42E4-AC85-EDF9FE50D4F1Q33555052-70111304-755E-4108-8976-9316ED9F696EQ33567426-BFD0008F-DB02-4A1E-98C9-81C4AB5D979DQ33581156-F544E4A4-5E6D-4388-9BE3-E28E028BF726Q33592941-4031C10C-074A-4301-BA56-A54540EA24C3Q33616812-4CF6557D-2BBD-4E0F-958D-F8CF98A0A348Q33618512-1E9614DD-55DB-4A4E-B5B0-06643C0D7CD3Q33660974-CE1BBE7B-2E84-42DA-A17C-2D4754AA1C0DQ33680701-C1064A8D-D88E-44F8-9C31-8F1C489E739AQ33685302-6EFBC4EF-8014-424F-894C-5DC0D2694756Q33733761-C51B3330-A56F-4586-A6C9-22853C6B9BD1Q33754007-42C3EE4C-D409-43A2-AC7C-2D3D8BF515A0Q33761894-668E6C36-A97E-4436-8868-2EFEE11E1206Q33775464-38A90A89-5245-471A-84D3-83D8BFED67D7Q33802655-2B7550C1-F9D8-467D-9E87-E39500BBBF77Q33907989-7DC2A6CF-63E6-4CCD-BE11-1D5FEB23E15BQ33976481-547CAFB4-1F45-4D6E-BBD1-D7857A243CBEQ34039349-57C71CFD-9D9C-4934-A432-083E4066117DQ34056283-CACDE1EB-0469-48B3-9DE1-FA3F29303EFFQ34062598-0C253409-B945-41ED-AA1C-D99CDB72ADD9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of hepatocellular carcinoma.
@en
Molecular mechanisms of hepatocellular carcinoma.
@nl
type
label
Molecular mechanisms of hepatocellular carcinoma.
@en
Molecular mechanisms of hepatocellular carcinoma.
@nl
prefLabel
Molecular mechanisms of hepatocellular carcinoma.
@en
Molecular mechanisms of hepatocellular carcinoma.
@nl
P2093
P356
P1433
P1476
Molecular mechanisms of hepatocellular carcinoma.
@en
P2093
Clifford J Steer
Erik N K Cressman
Rajagopal N Aravalli
P304
P356
10.1002/HEP.22580
P407
P577
2008-12-01T00:00:00Z